Shanghai HeartCare Medical Technology Corporation Ltd. has announced a proposal for the adoption of the 2025 H Share Incentive Scheme. This scheme includes H share awards aimed at aligning the interests of eligible participants with the long-term performance of the company. The adoption of this scheme is subject to approval by the shareholders at a general meeting. The Board, including independent non-executive directors, believes the scheme's terms are fair, reasonable, and in the best interest of the company and its shareholders.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai HeartCare Medical Technology Corporation Ltd. published the original content used to generate this news brief on May 07, 2025, and is solely responsible for the information contained therein.